Comment: This highly recommended firm specializing in medical law is still as busy as ever with AMNOG advice. The practice regularly gives advice on benefit assessments and represents its clients in numerous proceedings before the G-BA, sometimes right through to the arbitration board. Strategic advice is gaining in importance alongside compliance matters – the firm benefited here from the increased need for advice, esp. on the part of medical product companies. Headed by Ehlers, who is extremely well connected in the industry, the practice stands out among its competitors thanks to its work at the interface with healthcare policy, where it recently attracted two associations as new clients.
Strengths: Advice on healthcare policy, interface with physicians’ law.
Recommended: Prof. Dr. Dr. Alexander Ehlers, Dr. Christian Rybak.
Practice: Focus on social law and transactions. Also strategic advice in the run-up to product development. Very active in lobbying and healthcare policy for innovative companies. Also transactions, authorization, pharma advertising, medical products, compensation and compliance. Clients: pharma and biotech companies, manufacturers of medical products and associations. (4 partners, 6 associates)
Clients: ?? Novartis Pharma in AMNOG proceedings; all-round advice to Servier on benefit assessment and exclusion from prescriptions by the G-BA in the area of diabetes (also healthcare policy advice); Eusa Pharma in two G-BA proceedings; all-round advice to Unabhängige Patientenberatung Deutschland (UPD) on setup; Takeda on benefit assessment and unfair competition.
  • Teilen